Literature DB >> 26323434

Stimuli-Responsive Nanoparticles for siRNA Delivery.

Josimar O Eloy, Raquel Petrilli, Renata F V Lopez, Robert J Lee1.   

Abstract

Nanoparticles have been extensively employed to deliver many drugs, including siRNA, for the treatment of a variety of diseases, particularly cancer. Lately, there has been a great deal of effort to design nanoparticles with materials that are able to respond to intrinsic or extrinsic stimuli for "on demand" delivery of siRNA. These nanoparticles are able to trigger siRNA release upon different stimuli, such as a pH decrease, redox gradient, enzyme, light, magnetic field, temperature, ultrasound or electric current. Frequently, the stimuli cause the nanoparticles to undergo protonation, hydrolytic breakdown or phase transition for triggered release of siRNA, resulting in decreased side effects and better therapeutic outcome. While studies have demonstrated efficient in vitro and in vivo delivery, these "smart" nanoparticles have not yet reached the clinic. In this review, we address different classes of nanoparticles, such as polyplexes, lipoplexes, liposomes, polymeric micelles, polymeric, lipid and inorganic nanoparticles, that are able to respond to specific stimuli for siRNA triggered-release, emphasizing their application and discussing the latest advances.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323434     DOI: 10.2174/1381612821666150901095349

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.

Authors:  Ana Vanessa Nascimento; Florence Gattacceca; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Nanomedicine (Lond)       Date:  2016-03-16       Impact factor: 5.307

Review 2.  Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment.

Authors:  Rachel S Riley; Emily S Day
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-03

Review 3.  Trigger-Responsive Gene Transporters for Anticancer Therapy.

Authors:  Santhosh Kalash Rajendrakumar; Saji Uthaman; Chong Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2017-05-26       Impact factor: 5.076

4.  Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells.

Authors:  Rachel S Riley; Rachel K O'Sullivan; Andrea M Potocny; Joel Rosenthal; Emily S Day
Journal:  Nanomaterials (Basel)       Date:  2018-08-25       Impact factor: 5.076

Review 5.  RNA Nanotechnology-Mediated Cancer Immunotherapy.

Authors:  Yao-Xin Lin; Yi Wang; Sara Blake; Mian Yu; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.